合成路线1
该中间体在本合成路线中的序号:
(VII) The condensation of 2-(N-methylcarbamoylmethoxy)phenol (I) with 3-benzyloxy-1-(p-toluenesulfonyloxy)-2-propanol (II) by means of Na in refluxing methoxyethanol gives 3 benzyloxy-1-[2-(N-methylcarbamoylmethoxy)phenoxy]-2-propanol (III), which is debenzylated by hydrogenolysis with H2 over Pd/C in methanol yielding 1-[2-(N-methylcarbamoylmethoxy)phenoxy]-2,3-propanediol (IV). The tosylation of (IV) with tosyl chloride in pyridine affords 1-[2-(N-methylcarbamoylmethoxy)phenoxy]-3-tosyloxy-2-propanol (V), which by treatment with NaOH in water is converted into 1-[2-(N-methylcarbamoylmethoxy)phenoxy]-2,3-epoxypropane (VI). Finally, this compound is treated with tertbutylamine in refluxing tert-butanol.
【1】
Tucker, H.; FR 2250752 .
|
【2】
Hillier, K.; Castaner, J.; Blancafort, P.; Serradell, M.N.; Cetamolol hydrochloride. Drugs Fut 1983, 8, 4, 305.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36094 |
2-(2-hydroxyphenoxy)-N-methylacetamide
|
|
C9H11NO3 |
详情 |
详情
|
(II) |
36095 |
3-(benzyloxy)-2-hydroxypropyl 4-methylbenzenesulfonate
|
|
C17H20O5S |
详情 |
详情
|
(III) |
36096 |
2-[2-[3-(benzyloxy)-2-hydroxypropoxy]phenoxy]-N-methylacetamide
|
|
C19H23NO5 |
详情 |
详情
|
(IV) |
36097 |
2-[2-(2,3-dihydroxypropoxy)phenoxy]-N-methylacetamide
|
|
C12H17NO5 |
详情 |
详情
|
(V) |
36098 |
2-hydroxy-3-[2-[2-(methylamino)-2-oxoethoxy]phenoxy]propyl 4-methylbenzenesulfonate
|
|
C19H23NO7S |
详情 |
详情
|
(VI) |
36099 |
N-methyl-2-[2-(2-oxiranylmethoxy)phenoxy]acetamide
|
|
C12H15NO4 |
详情 |
详情
|
(VII) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) The condensation of tert-butylamine (II) with 2-(2-chloro-1-hydroxyethyl)-7-ethylbenzofuran (I) or with 2-epoxyehtyl-7-ethylbenzofuran (III) in refluxing ethanol.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
40321 |
2-chloro-1-(7-ethyl-1-benzofuran-2-yl)-1-ethanol
|
|
C12H13ClO2 |
详情 |
详情
|
(II) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(III) |
40322 |
7-ethyl-2-(2-oxiranyl)-1-benzofuran
|
|
C12H12O2 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) It can be prepared in two different ways:
1) The reaction of 1-chloro-2,3-propylene oxide (I) with tert-butylamine (II) in ether yields 1-chloro-3-tert-butylamino-2-propanol (III), which is condensed with 2,3-xylenol (IV) by means of KOH in ether-water.
2) By heating a mixture of 1-tert-butyl-3-azetidinol (V) and 2,3-xylenol (IV) at 155 C with KOH.
【1】
Suzuki, Y.; et al.; JP 45029294 .
|
【2】
Tsukamoto, K.; et al.; JP 46028534 .
|
【3】
Castaner, J.; Weetman, D.F.; D-32. Drugs Fut 1977, 2, 2, 91.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(II) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(III) |
31720 |
1-(tert-butylamino)-3-chloro-2-propanol
|
|
C7H16ClNO |
详情 |
详情
|
(IV) |
40074 |
2,3-dimethylphenol
|
526-75-0 |
C8H10O |
详情 | 详情
|
(V) |
40075 |
1-(tert-butyl)-3-azetidinol
|
13156-04-2 |
C7H15NO |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(C) This compound can be obtained in two different ways:
1) The reaction of cyclopropylmethyl ketone oxime (II) with epibromohydrin (A) in THF containing NaH gives O-[2,3-epoxypropyl]cyclopropylmethyl ketone oxime (III), which is treated with excess tert-butylamine (C) in ethanol yielding the final compound.
2) By condensation of cyclopropylmethyl ketone (I) with 3-(aminooxy)-N-tert-butyl-2-hydroxypropanamine (B) in ethanol.
【1】
Leclerc, G.; Bouzoubaa, M.; Andermann, G.; Ethers and oxime ethers of alkylamino alcohols as medicaments and novel products, and processes for their preparation. AU 1167283; EP 0087378; FR 2521856; JP 58154538; US 4766151 .
|
【2】
Schwartz, J.; Bieth, N.; Leclerc, G.; Synthesis and beta-adrenergic blocking activity of a new aliphatic oxime ethers. J Med Chem 1980, 23, 6, 620.
|
【3】
Castaner, J.; Serradell, M.N.; Falintolol oxalate. Drugs Fut 1984, 9, 7, 510.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
29679 |
2-(bromomethyl)oxirane
|
3132-64-7 |
C3H5BrO |
详情 | 详情
|
(B) |
34255 |
1-(aminooxy)-3-(tert-butylamino)-2-propanol
|
|
C7H18N2O2 |
详情 |
详情
|
(I) |
12435 |
Acetylcyclopropane; 1-Cyclopropyl-1-ethanone; Cyclopropylmethylketone
|
765-43-5 |
C5H8O |
详情 | 详情
|
(II) |
34253 |
1-cyclopropyl-1-ethanone oxime
|
|
C5H9NO |
详情 |
详情
|
(III) |
34254 |
1-cyclopropyl-1-ethanone O-(2-oxiranylmethyl)oxime
|
|
C8H13NO2 |
详情 |
详情
|
(C) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
The condensation of N-methyl-4-hydroxyisocarbostyril (I) with epichlorohydrin (II) by means of sodium methoxide in hot methanol gives 4-(2,3-epoxypropoxy)-N-methylisocarbostyril (III), which is then treated with tert-butylamine (IV) in methanol, and with HCl.
【1】
Fukushima, H.; Suzuki, Y. (Nisshin Flour Milling Co., Ltd.); Isocarbostyril derivatives. DE 2631080; GB 1501149; JP 52012178 .
|
【2】
Serradell, M.N.; Blancafort, P.; Thorpe, P.J.; Castaner, J.; N-696. Drugs Fut 1982, 7, 12, 889.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(I) |
32094 |
4-hydroxy-2-methyl-1(2H)-isoquinolinone
|
|
C10H9NO2 |
详情 |
详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
32095 |
2-methyl-4-(2-oxiranylmethoxy)-1(2H)-isoquinolinone
|
|
C13H13NO3 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(III) The oxidation of 2-chloroacetophenone (I) with SeO2 in dioxane-water gives 2-chlorophenylglyoxal (II), b.p. 87-90 C/1 mm, which is then reductocondensed with tert-butylamine (III) and NaSH4 in ethanol.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34006 |
1-(2-chlorophenyl)-1-ethanone
|
2142-68-9 |
C8H7ClO |
详情 | 详情
|
(II) |
34007 |
2-(2-chlorophenyl)-2-oxoacetaldehyde
|
|
C8H5ClO2 |
详情 |
详情
|
(III) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(A) The reaction of aminomethansulfonic acid (I) with phthalic anhydride (II) by means of potassium acetate in refluxing acetic acid gives phthalimidomethansulfonic acid (III), which by reaction with PCl5 in refluxing benzene is converted into its acyl chloride (IV). The condensation of (IV) with tert-butylamine (A) in CHCl3 affords N-tert-butylphthalimidomethansulfonamide (V), which by reaction with hydrazine hydrate in refluxing ethanol yields 2-aminomethan-N-tert-butylsulfonamide (VI). The reaction of (VI) with CS2 and MeI by means of triethylamine in ethanol gives N-tert-butylsulfamoylmethyldithiocarbamic acid methyl ester (VII), which is cyclized with NaN3 in hot water to afford 1-(N-tert-butylsulfamoylmethyl)tetrazol-5-thiol (VIII). The hydrolysis of (VIII) with trifluoroacetic acid yields compound 1-sulfamoylmethyltetrazol-5-thiol (IX).
【1】
Berges, D.A.; 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl)cephalosporins.. DE 2611270; FR 2304343; US 4048311 .
|
【2】
Castaner, J.; Serradell, M.N.; Thorpe, P.; Blancafort, P.; Cefonicid sodium. Drugs Fut 1979, 4, 9, 634.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(I) |
33363 |
aminomethanesulfonic acid
|
13881-91-9 |
CH5NO3S |
详情 | 详情
|
(II) |
11900 |
2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride |
85-44-9 |
C8H4O3 |
详情 | 详情
|
(III) |
33364 |
(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methanesulfonic acid
|
|
C9H7NO5S |
详情 |
详情
|
(IV) |
33365 |
(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methanesulfonyl chloride
|
|
C9H6ClNO4S |
详情 |
详情
|
(V) |
33366 |
N-(tert-butyl)(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methanesulfonamide
|
|
C13H16N2O4S |
详情 |
详情
|
(VI) |
33367 |
amino-N-(tert-butyl)methanesulfonamide
|
|
C5H14N2O2S |
详情 |
详情
|
(VII) |
33368 |
methyl [(tert-butylamino)sulfonyl]methylcarbamodithioate
|
|
C7H16N2O2S3 |
详情 |
详情
|
(VIII) |
33369 |
N-(tert-butyl)(5-sulfanyl-1H-1,2,3,4-tetraazol-1-yl)methanesulfonamide
|
|
C6H13N5O2S2 |
详情 |
详情
|
(IX) |
33370 |
(5-sulfanyl-1H-1,2,3,4-tetraazol-1-yl)methanesulfonic acid
|
|
C2H4N4O3S2 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(B) The esterification of 5,8-dihydro-1-naphthol (I) with acetic anhydride gives the corresponding acetate (II), which is oxidized with silver acetate and I2 in acetic acid to yield 2,3-cis-1,2,3,4-tetrahydro-2,3,5-naphthalenetriol (III). The treatment of this product with sodium methylate and epichlorhydrin (A) in methanol gives 2,3-cis-1,2,3,4-tetrahydro-5-(2,3-epoxypropoxy)-2,3-naphthalenediol (IV), which is finally treated with tertbutylamine (B) in chloroform-methanol.
【1】
Hanck, F.P.; et al.; Tetrahydronaphthyloxyaminopropanols and related compounds. CA 979926; DE 2258995; GB 1358722 .
|
【2】
Weetman, D.F.; Castaner, J.; Nadolol. Drugs Fut 1976, 1, 9, 434.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(B) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(I) |
40440 |
5,8-dihydro-1-naphthalenol
|
27673-48-9 |
C10H10O |
详情 | 详情
|
(II) |
40441 |
1-naphthyl acetate
|
830-81-9 |
C12H10O2 |
详情 | 详情
|
(III) |
40442 |
(6R,7S)-5,6,7,8-tetrahydro-1,6,7-naphthalenetriol
|
|
C10H12O3 |
详情 |
详情
|
(IV) |
40443 |
(2R,3S)-5-(2-oxiranylmethoxy)-1,2,3,4-tetrahydro-2,3-naphthalenediol
|
|
C13H16O4 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(B) By reaction of 5,8-dihydro-1-(2,3-epoxypropoxy)naphthalene (V) with tertbutylamine (B) to give 5,8-dihydro-1-[2-hydroxy-3-(tertbutylamino)propoxy]naphthalene (VI), followed by oxidation of the double bond with silver acetate and I2 in acetic acid.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(V) |
40444 |
5,8-dihydro-1-naphthalenyl 2-oxiranylmethyl ether; 2-[(5,8-dihydro-1-naphthalenyloxy)methyl]oxirane
|
|
C13H14O2 |
详情 |
详情
|
(VI) |
40445 |
1-(tert-butylamino)-3-(5,8-dihydro-1-naphthalenyloxy)-2-propanol
|
|
C17H25NO2 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(VII) A new method for the synthesis of pirbuterol hydrochloride has been described:
By reaction of 2-phenyl-4H-1,3-dioxino[5,4-b]pyridine-6-carbaldehyde (I) with methyltriphenylphosphonium bromide (II) and NaOH in toluene to give 2-phenyl-6-vinyl-4H-1,3-dioxino[5,4-b]pyridine (III), which is treated with m-chloroperbenzoic acid (IV) in methylene chloride to give 6-(1,2-epoxyethyl)-2-phenyl-4H-1,3-dioxino[5,4-b]pyridine N-oxide (V). Compound (V) can also be obtained from 6-(1,2-epoxyethyl)-2-phenyl-4H-1,3-dioxino[5,4-b]pyridine (VI) by reaction with m-chloroperbenzoic acid (IV) as before.
The reaction of (V) with tert-butylamine (VII) in methanol affords 6-(1-hydroxy-2-tert-butylaminoethyl)-2-phenyl-4H-1,3-dioxino[5,4-b]pyridine N-oxide (VIII), which is first treated with H2 over Pd/C in methanol and then with HCl in ethyl acetate to give pirbuterol hydrochloride.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30711 |
2-phenyl-4H-[1,3]dioxino[5,4-b]pyridine-6-carbaldehyde
|
|
C14H11NO3 |
详情 |
详情
|
(II) |
30484 |
Methyl(triphenyl)phosphonium bromide
|
1779-49-3 |
C19H18BrP |
详情 | 详情
|
(III) |
30712 |
2-phenyl-6-vinyl-4H-[1,3]dioxino[5,4-b]pyridine
|
|
C15H13NO2 |
详情 |
详情
|
(V) |
30713 |
6-(2-oxiranyl)-2-phenyl-4H-[1,3]dioxino[5,4-b]pyridin-5-ium-5-olate
|
|
C15H13NO4 |
详情 |
详情
|
(VI) |
30714 |
6-(2-oxiranyl)-2-phenyl-4H-[1,3]dioxino[5,4-b]pyridine
|
|
C15H13NO3 |
详情 |
详情
|
(VII) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(VIII) |
30715 |
6-[2-(tert-butylamino)-1-hydroxyethyl]-2-phenyl-4H-[1,3]dioxino[5,4-b]pyridin-5-ium-5-olate
|
|
C19H24N2O4 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(IV) The reaction of 2-cyclopentylphenol (I) with epichlorhydrin (II) in a basic medium yields 1,2-epoxy-3-(2'-cyclopentylphenoxy)propane (III), which is the condensed with tert-butylamine (IV) in hot ethanol.
【1】
Ruschig, H.; et al.; ZA 6807915 .
|
【2】
Castaner, J.; Weetman, D.F.; Penbutolol. Drugs Fut 1976, 1, 10, 494.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
40452 |
2-cyclopentylphenol
|
|
C11H14O |
详情 |
详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
40453 |
2-cyclopentylphenyl 2-oxiranylmethyl ether; 2-[(2-cyclopentylphenoxy)methyl]oxirane
|
28163-40-8 |
C14H18O2 |
详情 | 详情
|
(IV) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(VIII) The reaction of cyclohexane-1,3-dione (I) with ammonia gives 3-amino-2-cyclohexen-1-one (II), which is cyclized with acrylic acid (III) by heating at 140 C yielding 1,2,3,4,5,6,7,8-octahydroquinoline-2,5-dione (IV). The dehydrogenation of (IV) by means of Pd/C in refluxing decaline affords 5-hydroxy-1,2,3,4-tetrahydroquinolin-2-one (V), which is condensed with epichlorohydrin (VI) by means of NaOMe or NaOH in methanol giving 5-(2,3-epoxypropoxy)-1,2,3,4-tetrahydroquinolin-2-one (VII). Finally, this compound is treated with tert-butylamine in methanol.
【1】
Castaner, J.; Sungurbey, K.; Carteolol. Drugs Fut 1977, 2, 5, 288.
|
【2】
Shono, T.; et al.; A new practical synthesis of 5-hydroxy-3,4-dihydrocarbostyril and 5-hydroxycarbostyril. J Org Chem 1981, 46, 3719.
|
【3】
Von Winkler, W.; Chemical and analytical data for the pharmaceutically active substance carteolol hydrochloride. Arzneim-Forsch Drug Res 1983, 33, 2a, 279.
|
【4】
Mori, H.; Tamura, Y,.; Tominaga, M.; Yoshiaki, S.; Nakagawa, K.; Murakami, N. (Otsuka Pharmaceutical Co., Ltd.); 3,4-Dihydrocarbostyril derivs., their preparation, and pharmaceutical compsns. thereof. DE 2302027; GB 1424571 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11244 |
1,3-Cyclohexanedione
|
504-02-9 |
C6H8O2 |
详情 | 详情
|
(II) |
31475 |
3-amino-2-cyclohexen-1-one
|
5220-49-5 |
C6H9NO |
详情 | 详情
|
(III) |
19139 |
acrylic acid
|
79-10-7 |
C3H4O2 |
详情 | 详情
|
(IV) |
31476 |
4,6,7,8-tetrahydro-2,5(1H,3H)-quinolinedione
|
|
C9H11NO2 |
详情 |
详情
|
(V) |
31477 |
5-hydroxy-3,4-dihydro-2(1H)-quinolinone
|
|
C9H9NO2 |
详情 |
详情
|
(VI) |
29648 |
2-oxiranylmethanol
|
556-52-5 |
C3H6O2 |
详情 | 详情
|
(VII) |
31478 |
5-(2-oxiranylmethoxy)-3,4-dihydro-2(1H)-quinolinone
|
|
C12H13NO3 |
详情 |
详情
|
(VIII) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(VI) The condensation of 3-acetyl-4-hydroxyaniline (I) with N,N-diethylcarbamoyl chloride (II) in pyridine gives the urea (II), which is treated with epichlorohydrin (IV) and NaOH to yield N-[3-acetyl-4-(2,3-epoxypropoxy)phenyl]-N',N'-diethylurea (V). Finally, the epoxy ring of (V) is opened with tert-butylamine (VI).
【1】
Stormann-Menninger-Lerchenthal, H.; Pittner, H.; Zolss, G. (CL Pharma); 4-Ureido-2-acyl phenoxypropanolamine. DE 2458624; US 4034009 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
33815 |
1-(5-amino-2-hydroxyphenyl)-1-ethanone
|
|
C8H9NO2 |
详情 |
详情
|
(II) |
33816 |
N,N'-Diethylcarbamoyl chloride; 1-[(chlorocarbonyl)(ethyl)amino]ethane
|
88-10-8 |
C5H10ClNO |
详情 | 详情
|
(III) |
33817 |
N'-(3-acetyl-4-hydroxyphenyl)-N,N-diethylurea
|
|
C13H18N2O3 |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
33818 |
N'-[3-acetyl-4-(2-oxiranylmethoxy)phenyl]-N,N-diethylurea
|
|
C16H22N2O4 |
详情 |
详情
|
(VI) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(VI) The reaction of 3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy)aniline (VII) with phenyl carbamate (VIII) in pyridine gives the N-[3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenylcarbamic acid phenyl ester (IX), which is tretated with diethylamine (X) in ethanol/water.
By reaction of N-[3-acetyl-4-(3-chloro-2-hydroxypropoxy)phenyl]-N',N'-diethylurea (XI) with tert-butylamine (VI).
【1】
Stormann-Menninger-Lerchenthal, H.; Pittner, H.; Zolss, G. (CL Pharma); 4-Ureido-2-acyl phenoxypropanolamine. DE 2458624; US 4034009 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(VII) |
33819 |
1-[5-amino-2-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1-ethanone
|
|
C15H24N2O3 |
详情 |
详情
|
(VIII) |
33820 |
phenyl carbamate
|
622-46-8 |
C7H7NO2 |
详情 | 详情
|
(IX) |
33821 |
phenyl 3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenylcarbamate
|
|
C22H28N2O5 |
详情 |
详情
|
(X) |
24486 |
Diethylamine; N,N-Diethylamine
|
109-89-7 |
C4H11N |
详情 | 详情
|
(XI) |
33822 |
N'-[3-acetyl-4-(3-chloro-2-hydroxypropoxy)phenyl]-N,N-diethylurea
|
|
C16H23ClN2O4 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(A) There are several pathways for the preparation of the title compound according to the patent literature.
【1】
Zoelss, G.; AT 335464 .
|
【2】
Koch, H.; Celiprolol hydrocloride. Drugs Fut 1979, 4, 3, 181.
|
【3】
Zoelss, G.; AT 335467 .
|
【4】
Zoelss, G.; AT 335465 .
|
【5】
Zoelss, G.; et al.; AT 334385 .
|
【6】
Celiprolol - ein kardioselektiver beta-rezeptorblocker. Chemie Linz Ag (Kurzinformation), UL/2007, (Nov. 1978) 1978.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(D) |
24486 |
Diethylamine; N,N-Diethylamine
|
109-89-7 |
C4H11N |
详情 | 详情
|
(B) |
33816 |
N,N'-Diethylcarbamoyl chloride; 1-[(chlorocarbonyl)(ethyl)amino]ethane
|
88-10-8 |
C5H10ClNO |
详情 | 详情
|
(I) |
33818 |
N'-[3-acetyl-4-(2-oxiranylmethoxy)phenyl]-N,N-diethylurea
|
|
C16H22N2O4 |
详情 |
详情
|
(II) |
33819 |
1-[5-amino-2-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1-ethanone
|
|
C15H24N2O3 |
详情 |
详情
|
(III) |
33817 |
N'-(3-acetyl-4-hydroxyphenyl)-N,N-diethylurea
|
|
C13H18N2O3 |
详情 |
详情
|
(IV) |
39491 |
N-[3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]urea
|
|
C16H25N3O4 |
详情 |
详情
|
(V) |
33821 |
phenyl 3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenylcarbamate
|
|
C22H28N2O5 |
详情 |
详情
|
(C) |
31720 |
1-(tert-butylamino)-3-chloro-2-propanol
|
|
C7H16ClNO |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(VIII) The condensation of 4-ethoxyaniline (II) with N,N-diethylcarbamoyl chloride (II) by means of KHCO3 gives the urea (III), which is acylated with acetyl chloride and AlCl3 to yield N-(3-acetyl-4-hydroxyphenyl)-N',N'-diethylurea (IV). The alkylation of (IV) with epichlorohydrin (V) affords the adduct (VI), which is treated with HBr providing the bromoalcohol (VII). Finally this compound is treated with tert-butylamine to furnish the target urea.
【1】
Zolss, G.; On the synthesis of the cardioselective beta-adrenergic receptor blocking agent celiprolol. Arzneim-Forsch Drug Res 1983, 33, 1a, 2.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
45939 |
4-Aminophenetole; 1-Amino-4-ethoxybenzene; 4-Aminoethoxybenzene; 4-Ethoxyphenylamine; p-Phenetidine; 4-Ethoxyaniline
|
156-43-4 |
C8H11NO |
详情 | 详情
|
(II) |
33816 |
N,N'-Diethylcarbamoyl chloride; 1-[(chlorocarbonyl)(ethyl)amino]ethane
|
88-10-8 |
C5H10ClNO |
详情 | 详情
|
(III) |
45940 |
N'-(4-ethoxyphenyl)-N,N-diethylurea
|
|
C13H20N2O2 |
详情 |
详情
|
(IV) |
33817 |
N'-(3-acetyl-4-hydroxyphenyl)-N,N-diethylurea
|
|
C13H18N2O3 |
详情 |
详情
|
(V) |
29776 |
1-(chloromethyl)cyclopropane
|
5911-08-0 |
C4H7Cl |
详情 | 详情
|
(VI) |
45941 |
N'-[3-acetyl-4-(cyclopropylmethoxy)phenyl]-N,N-diethylurea
|
|
C17H24N2O3 |
详情 |
详情
|
(VII) |
45942 |
N'-[3-acetyl-4-(3-bromo-2-hydroxypropoxy)phenyl]-N,N-diethylurea
|
|
C16H23BrN2O4 |
详情 |
详情
|
(VIII) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
(XI) The reaction of D-mannitol (I) with acetone and ZnCl2 gives the diacetonide (II), which is oxidized with Pb(OAc)4 to yield the acetonide of (R)-glyceraldehyde (III). The reduction of (III) with H2 over Pd/C affords the (S)-glycerin acetonide (IV), which is treated with TsCl in pyridine to provide the corresponding tosylate (V). The condensation of (V) with the urea derivative (VI) by means of KOH in DMSO gives the adduct (VII), which is deprotected with HCl in acetone to yield the diol (VIII). Monotosylation of (VIII) with TsCl in pyridine affords the primary tosylate (IX), which is treated with Na in methanol to provide the epoxide (X). Finally this compound is treated with tert-butylamine to furnish the target (R)-enantiomer.
【1】
Hofer, O.; Schlogl, K.; Absolute configuration and enantiomeric purity of celiprolol. Arzneim-Forsch Drug Res 1986, 36, 8, 1157.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
45943 |
(2R,3R,4R,5R)-1,2,3,4,5-heptanepentol
|
|
C7H16O5 |
详情 |
详情
|
(II) |
45944 |
(1S,2S)-1,2-bis[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-1,2-ethanediol
|
1707-77-3 |
C12H22O6 |
详情 | 详情
|
(III) |
36759 |
(4R)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde
|
15186-48-8 |
C6H10O3 |
详情 | 详情
|
(IV) |
12698 |
[(4R)-2,2-Dimethyl-1,3-dioxolan-4-yl]methanol
|
14347-78-5 |
C6H12O3 |
详情 | 详情
|
(V) |
15208 |
(S)-(+)-2,2-Dimethyl-4-(hydroxymethyl)-1,3-dioxolane-p-toluenesulfonate; [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 4-methylbenzenesulfonate
|
23735-43-5 |
C13H18O5S |
详情 | 详情
|
(VI) |
33817 |
N'-(3-acetyl-4-hydroxyphenyl)-N,N-diethylurea
|
|
C13H18N2O3 |
详情 |
详情
|
(VII) |
45945 |
N'-(3-acetyl-4-[[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]phenyl)-N,N-diethylurea
|
|
C19H28N2O5 |
详情 |
详情
|
(VIII) |
45946 |
N'-(3-acetyl-4-[[(2R)-2,3-dihydroxypropyl]oxy]phenyl)-N,N-diethylurea
|
|
C16H24N2O5 |
详情 |
详情
|
(IX) |
45947 |
(2S)-3-(2-acetyl-4-[[(diethylamino)carbonyl]amino]phenoxy)-2-hydroxypropyl 4-methylbenzenesulfonate
|
|
C23H30N2O7S |
详情 |
详情
|
(X) |
45948 |
N'-[3-acetyl-4-[(2R)oxiranylmethoxy]phenyl]-N,N-diethylurea
|
|
C16H22N2O4 |
详情 |
详情
|
(XI) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线18
该中间体在本合成路线中的序号:
(VI) The reaction of 4-nitrophenol (I) with acetic anhydride in aqueous NaOH gives the corresponding acetate (II), which is submitted to a Fries migration with AlCl3 in nitrobenzene at 140 C to yield the acetophenone (III). The condensation of (III) with epichlorohydrin (IV) by means of K2CO3 affords the adduct (V), which is treated with tert-butylamine (VI) in water to obtain the aminoisopropanol derivative (VII). The reduction of the nitro group of (VII) with H2 over Pd/C in methanol gives the corresponding amino derivative (VIII), which is finally condensed with N,N-diethylcarbamoyl chloride (IX) by means of TEA in THF to yield the target urea.
【1】
Joshi, R.A.; et al.; A new and improved process for celiprolol hydrochloride. Org Process Res Dev 2001, 5, 2, 176.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11236 |
4-Nitrophenol; p-Nitrophenol
|
100-02-7 |
C6H5NO3 |
详情 | 详情
|
(II) |
50841 |
4-Nitrophenyl acetate; Acetic acid 4-nitrophenyl ester; p-Nitrophenyl acetate
|
830-03-5 |
C8H7NO4 |
详情 | 详情
|
(III) |
50842 |
1-(2-hydroxy-5-nitrophenyl)-1-ethanone
|
|
C8H7NO4 |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
50843 |
1-[5-nitro-2-(2-oxiranylmethoxy)phenyl]-1-ethanone
|
|
C11H11NO5 |
详情 |
详情
|
(VI) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(VII) |
50844 |
1-[2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-nitrophenyl]-1-ethanone
|
|
C15H22N2O5 |
详情 |
详情
|
(VIII) |
33819 |
1-[5-amino-2-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1-ethanone
|
|
C15H24N2O3 |
详情 |
详情
|
(IX) |
33816 |
N,N'-Diethylcarbamoyl chloride; 1-[(chlorocarbonyl)(ethyl)amino]ethane
|
88-10-8 |
C5H10ClNO |
详情 | 详情
|
合成路线19
该中间体在本合成路线中的序号:
(IV) The reaction of 5-hydroxy-7-tetralone (I) with epichlorohydrin (I) at reflux temperature gives 5-(3-chloro-2-hydroxypropoxy)-7-tetralone (III), which is then condensed with butylamine (IV) in refluxlng alcohol.
【1】
Shavel, J.Jr.; Farber, S. (Pfizer Inc.); 3,4-Dihydroxynaphtalenoneoxy-2-hydroxypropylamines. BE 0739195; DE 1948144; DE 1967162; FR 2018626; GB 1223527; JP 48043734B; US 3641152 .
|
【2】
Castaner, J.; Serradell, M.N.; Weetman, D.F.; Blancafort, P.; Levobunolol Hydrochloride. Drugs Fut 1983, 8, 9, 788.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
31099 |
5-hydroxy-3,4-dihydro-1(2H)-naphthalenone
|
28315-93-7 |
C10H10O2 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
31100 |
5-(3-chloro-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone
|
|
C13H15ClO3 |
详情 |
详情
|
(IV) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线20
该中间体在本合成路线中的序号:
(B) It can be obtained in two different ways both starting from the sodium salt of 5-hydroxy-3,4-dihydro-1(2H)-naphthalenone (I):
1) Its condensation with epichlorhydrine (A) in ethanol gives 5-(2,3-epoxypropoxy)-3,4-dihydro-1(2H)-naphthalenone (II), which is then condensed with tert-butylamine (B) in refluxing ethanol.
2) Its condensation with 3-chloro-1,2-propanediol (C) gives 5-(2,3-dihydroxy-propoxy)-3,4-dihydro-1(2H)-naphthalenone (III), which is esterified with tosyl chloride to the sulfonic ester (IV), and finally condensed with tert-butylamine.
【1】
Merrill, E.J.; Synthesis of 14C-labeled Bunolol. J Pharm Sci 1971, 60, 10, 1589-91.
|
【2】
Castaner, J.; Arrigoni-Martelli, E.; Bunolol. Drugs Fut 1976, 1, 9, 403.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(B) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(I) |
40456 |
sodium 5-oxo-5,6,7,8-tetrahydro-1-naphthalenolate
|
|
C10H9NaO2 |
详情 |
详情
|
(II) |
40457 |
5-(2-oxiranylmethoxy)-3,4-dihydro-1(2H)-naphthalenone
|
|
C13H14O3 |
详情 |
详情
|
(III) |
40458 |
5-(2,3-dihydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone
|
|
C13H16O4 |
详情 |
详情
|
(IV) |
40459 |
2-hydroxy-3-[(5-oxo-5,6,7,8-tetrahydro-1-naphthalenyl)oxy]propyl 4-methylbenzenesulfonate
|
|
C20H22O6S |
详情 |
详情
|
(C) |
12975 |
3-Chloro-1,2-propanediol; Glycerol alpha-monochlorohydrin
|
96-24-2 |
C3H7ClO2 |
详情 | 详情
|
合成路线21
该中间体在本合成路线中的序号:
(B) By reaction of alpha,m-(dichloropropiophenone (I) with tert-butylamine (B) in refluxing acetonitrile or by reaction of alpha-bromo-m-chloropropiophenone (VI) with tert-butylamine (B) in acetonitrile at room temperature.
The starting product (I) can be obtained in two different ways:
1) The Grignard condensation of m-chlorobenzonitrile (II) with ethyl magnesium bromide (A) in refluxing ether gives m-chloropropiophenone (III), which is then treated with SO2Cl2 in tetrachloroethane.
2) The reaction of propiophenone (IV) with SO2Cl2 in tetrachloroethane gives alpha-chloropropiophenone (V), which is then chlorinated in the ring by means of SO2Cl2 and AlCl3 in tetrachloroethane.
The starting product (VI) is obtained by bromination of m-chloropropiophenone (III) with Br2 in methylene chloride
【1】
Mehta, N.B.; Yeowell, D.A.; Intermediates for biologically active ketones. CA 977778 .
|
【2】
Mehta, N.B.; Yeowell, D.A.; Amino-propiophenones et medicaments contenant ces substances. DE 2059618; DE 2064934; FR 2081326; US 3819706 .
|
【3】
Hopkins, S.J.; Castaner, J.; Bupropion. Drugs Fut 1978, 3, 10, 723.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(A) |
24239 |
bromo(ethyl)magnesium;ethylmagnesium bromide |
925-90-6 |
C2H5BrMg |
详情 | 详情
|
(I) |
33569 |
2-chloro-1-(3-chlorophenyl)-1-propanone
|
|
C9H8Cl2O |
详情 |
详情
|
(II) |
33570 |
3-chlorobenzonitrile
|
766-84-7 |
C7H4ClN |
详情 | 详情
|
(III) |
33571 |
3'-chloropropiophenone; 1-(3-chlorophenyl)-1-propanone
|
34841-35-5 |
C9H9ClO |
详情 | 详情
|
(IV) |
33531 |
propiophenone
|
93-55-0 |
C9H10O |
详情 | 详情
|
(V) |
33572 |
2-chloro-1-phenyl-1-propanone
|
|
C9H9ClO |
详情 |
详情
|
(VI) |
33573 |
2-bromo-1-(3-chlorophenyl)-1-propanone
|
|
C9H8BrClO |
详情 |
详情
|
合成路线22
该中间体在本合成路线中的序号:
(C) The nitration of 8-hydroxy-3,4-dihydrocarbostyril (I) with HNO3 in acetic acid-acetic anhydride gives 5-nitro-8-hydroxy-3,4-dihydrocarbostyril (II), which is reduced with SnCl2 in concentrated HCl yielding 5-amino-8-hydroxy-3,4-dihydrocarbostyril (III). The oxidation of (III) with FeCl3 in aqueous HCl affords 5,8-dioxo-3,4,5,8-tetrahydrocarbostyril (IV), which by treatment with SO2 in water is converted into 5,8-dihydroxy-3,4-dihydrocarbostyril (V). The treatment of (V) with benzyl chloride (A) and potassium carbonate in acetone gives 5-hydroxy-8-benzyloxy-3,4-dihydrocarbostyril (VII), which by reaction with epichlorohydrin (B) by means of piperidine affords 8-benzyloxy-5-(2,3-epoxypropoxy)-3,4-dihydrocarbostyril (VII). The opening of the epoxide ring of (VII) with tert-butylamine (C) in methanol yields 8-benzyloxy-5-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydrocarbostyril (VIII) (1,2), which is finally hydrogenated with H2 over Pd/C.
【1】
Castaner, J.; Blancafort, P.; Serradell, M.N.; 8-Hydroxycarteolol. Drugs Fut 1980, 5, 2, 78.
|
【2】
Uchida, M.; et al.; Synthesis of 5-(3-tert-butylamino-2-hydroxypropxy)-8-3,4-dihydrocarbostyril hydochloride and its beta-adrenergic blocking agent. Yakugaku Zasshi 1976, 96, 5, 571-577.
|
【3】
Nakagawa, K.; et al.; US 4072683 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(A) |
19171 |
1-(Chloromethyl)benzene; Benzyl chloride
|
100-44-7 |
C7H7Cl |
详情 | 详情
|
(I) |
39062 |
8-hydroxy-3,4-dihydro-2(1H)-quinolinone
|
22246-18-0 |
C9H9NO2 |
详情 | 详情
|
(II) |
39063 |
8-hydroxy-5-nitro-3,4-dihydro-2(1H)-quinolinone
|
|
C9H8N2O4 |
详情 |
详情
|
(III) |
39064 |
5-amino-8-hydroxy-3,4-dihydro-2(1H)-quinolinone
|
|
C9H10N2O2 |
详情 |
详情
|
(IV) |
39065 |
3,4,4a,8a-tetrahydro-2,5,8(1H)-quinolinetrione
|
|
C9H9NO3 |
详情 |
详情
|
(V) |
39066 |
5,8-dihydroxy-3,4-dihydro-2(1H)-quinolinone
|
|
C9H9NO3 |
详情 |
详情
|
(VI) |
39067 |
8-(benzyloxy)-5-hydroxy-3,4-dihydro-2(1H)-quinolinone
|
|
C16H15NO3 |
详情 |
详情
|
(VII) |
39068 |
8-(benzyloxy)-5-(2-oxiranylmethoxy)-3,4-dihydro-2(1H)-quinolinone
|
|
C19H19NO4 |
详情 |
详情
|
(VIII) |
39069 |
8-(benzyloxy)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2(1H)-quinolinone
|
|
C23H30N2O4 |
详情 |
详情
|
(C) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线23
该中间体在本合成路线中的序号:
(III) By bromination of 4-amino-3,5-dichloroacetophenone (I) with Br2 in CHCl3 to give 4-amino-3,5-dichloro-alpha-bromoacetophenone (II), m.p. 140-5 C, which is condensed with tert-butylamine (III) in CHCl3 to 4-amino-3,5-dichloro-alpha-tertbutylaminoacetophenone hydrochloride (IV), m.p. 252-7 C; this product is finally reduced with NaBH4 in methanol.
【1】
Keck, J.; et al.; Neue Verbindung 1-(4-Amino-3,5-dichlorphenyl)-2-tert-butylamino-athanol. DE 1793416 .
|
【2】
Keck, J.; et al.; Synthesen von neuen Amino-Halogen-substituierten Phenyl-aminoathanolen. Arzneim-Forsch Drug Res 1972, 22, 5, 861-869.
|
【3】
Castaner, J.; Thorpe, P.; Clenbuterol. Drugs Fut 1976, 1, 5, 221.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34002 |
1-(4-amino-3,5-dichlorophenyl)-1-ethanone; 4-amino-3,5-dichloroacetophenone
|
37148-48-4 |
C8H7Cl2NO |
详情 | 详情
|
(II) |
34003 |
1-(4-amino-3,5-dichlorophenyl)-2-bromo-1-ethanone
|
|
C8H6BrCl2NO |
详情 |
详情
|
(III) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(IV) |
34004 |
1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)-1-ethanone
|
|
C12H16Cl2N2O |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(VI) The formylation of 5-hydroxy-1,2,3,4-tetrahydroisoquinoline (I) with formamide (II) at 140 C gives N-formyl-5-hydroxy-1,2,3,4-tetrahydroisoquinoline (III), which is condensed with epichlorohydrin (IV) by means of NaOH in water yielding N-formyl-5-(2,3-epoxypropoxy)-1,2,3,4-tetrahydroisoquinoline (V). Finally, this compound is condensed with tert-butylamine (VI).
【1】
Knoll, A.-G. (Knoll AG); Isoquinoline derivatives. NL 7513301 .
|
【2】
Westermann, A.; Zimmermann, F.; Wuppermann, D.; Friedrich, L.; Raschack, M. (Knoll AG.); New isoquinoline derivatives. DE 2620179 .
|
【3】
Prous, J.; Castaner, J.; SOQUINOLOL MUCATE < Rec INNM >. Drugs Fut 1989, 14, 5, 439.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20879 |
1,2,3,4-tetrahydro-5-isoquinolinol
|
|
C9H11NO |
详情 |
详情
|
(III) |
20880 |
5-hydroxy-3,4-dihydro-2(1H)-isoquinolinecarbaldehyde
|
|
C10H11NO2 |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
20882 |
5-(2-oxiranylmethoxy)-3,4-dihydro-2(1H)-isoquinolinecarbaldehyde
|
|
C13H15NO3 |
详情 |
详情
|
(VI) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线25
该中间体在本合成路线中的序号:
(IV) The reaction of (E)-6-(3-aminophenyl)-6-(3-pyridyl)-5-hexenoic acid methyl ester (I) with diphenyl N-cyanocarbinimidate (II) in isopropanol gives the N-cyanoisourea (III), which is condensed with tert-butylamine (IV) in refluxing isopropanol yielding the guanidine derivative (IV). Finally, hydrolysis of the ester group of (IV) with NaOH affords the target compound.
【1】
Soyka, R.; et al.; Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors. J Med Chem 1999, 42, 7, 1235.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25867 |
methyl (E)-6-(3-aminophenyl)-6-(3-pyridinyl)-5-hexenoate
|
|
C18H20N2O2 |
详情 |
详情
|
(II) |
25868 |
1-[(cyanoimino)(phenoxy)methoxy]benzene
|
107-37-9 |
C14H10N2O2 |
详情 | 详情
|
(III) |
25869 |
methyl (E)-6-(3-[[(cyanoimino)(phenoxy)methyl]amino]phenyl)-6-(3-pyridinyl)-5-hexenoate
|
|
C26H24N4O3 |
详情 |
详情
|
(IV) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(V) |
25870 |
methyl (E)-6-(3-[[(tert-butylamino)(cyanoimino)methyl]amino]phenyl)-5-methyl-6-(3-pyridinyl)-5-hexenoate
|
|
C25H31N5O2 |
详情 |
详情
|
合成路线26
该中间体在本合成路线中的序号:
(XX) Finally, the target compound has been obtained as follows: The selective esterification of the phosphono group of intermediate (IX) with iodomethyl pivalate (XVIII) by means of triethylamine in DMF gives the sulfonic acid (XIX), which was purified through its calcium salt. Finally, this compound is treated with tert-butylamine in methanol to afford the target salt.
【1】
Pendri, Y.; Chen, C.-P.; Kucera, D.J.; Martinez, E.J.; Pansegrau, P.; Thottathil, J.K.; Timmins, P. (Bristol-Myers Squibb Co.); Phosphonosulfonate squalene synthetase inhibitor salts and method. CA 2159850; EP 0710665; JP 1996208672 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
30173 |
(1S)-4-(3-phenoxyphenyl)-1-phosphono-1-butanesulfonic acid
|
|
C16H19O7PS |
详情 |
详情
|
(XVIII) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
(XIX) |
30182 |
(1S)-1-(bis[[(2,2-dimethylpropanoyl)oxy]methoxy]phosphoryl)-4-(3-phenoxyphenyl)-1-butanesulfonic acid
|
|
C28H39O11PS |
详情 |
详情
|
(XX) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线27
该中间体在本合成路线中的序号:
(VI) Nitration of minocycline (I) with KNO3 and H2SO4 gives the 9-nitro derivative (II), which is reduced with H2 over Pd/C in 2-methoxyethanol/2N H2SO4 to provide 9-aminominocycline (III). Acylation of compound (III) with 2-bromoacetyl bromide (IV) in N,N-dimethylpropyleneurea (DMPU) affords 9-(2-bromoacetamido)minocycline (V). Finally, this compound is treated with tert-butylamine (VI) to yield, after purification, GAR-936.
【1】
Hunter, P.A.; Castaner, J.; GAR-936. Drugs Fut 2001, 26, 9, 851.
|
【2】
Sum, P.-E.; Petersen, P.; Synthesis and structure-activity relationship of novel glycylcline derivatives leading to the discovery of GAR-936. Bioorg Med Chem Lett 1999, 9, 10, 1459.
|
【3】
Sum, P.-E.; Lee, V.J. (American Cyanamid Co.); Method of producing 7-(substd.)-9-[(substd. glycyl)amidol]-6-demethyl-6-deoxytetracyclines. EP 0582790; US 5284963 .
|
【4】
Sum, P.-E.; Lee, V.J.; Testa, R.T.; Hlavka, J.J.; Ellestad, G.A.; Bloom, J.D.; Gluzman, Y.; Tally, F.P.; Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines. J Med Chem 1994, 37, 1, 184-8.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16360 |
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide
|
10118-90-8 |
C23H27N3O7 |
详情 | 详情
|
(II) |
16361 |
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide
|
|
C23H26N4O9 |
详情 |
详情
|
(III) |
16362 |
(4S,4aS,5aR,12aS)-9-amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide
|
|
C23H28N4O7 |
详情 |
详情
|
(IV) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(V) |
48570 |
(4S,4aS,5aR,12aS)-9-[(2-bromoacetyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide
|
|
C25H29BrN4O8 |
详情 |
详情
|
(VI) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(VII) |
48571 |
2-(tert-butylamino)acetyl chloride
|
|
C6H12ClNO |
详情 |
详情
|
合成路线28
该中间体在本合成路线中的序号:
(VI) The reacion of 3-(trifluoromethyl) benzoic acid (I) first with SOCl2 (or oxalyl chloride) and then with NH4OH in dioxane given the corresponding amide (II), which is treated with SOCl2 giving 3-(trifluoromethyl)benzonitrile (III) was condensed with ethylmagnesium bromide to afford ketone (IV), which was brominated in either methanol or dioxane to yield bromoketone (V). Alkylation of tert-butylamine (VI) with bromoketone (V) provided the aminoketone (VII). Reduction of this ketone to the aminoalcohol was performed with several reagents, among them, borane in THF afforded the most favourable ratio for the desired treo diastereoisomer (80:20). Finally, the diastereomeric mixture was separated by preparative HPLC.
【1】
Musso, D.L.; et al.; Synthesis and evaluation of the anticonvulsant activity of a series of 2-amino-1-phenyl-1-propanols derived from the metabolites of the antidepressant bupropion. Bioorg Med Chem Lett 1997, 7, 1, 1.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17890 |
3-(trifluoromethyl)benzoic acid; m-Trifluoromethylbenzoic acid
|
454-92-2 |
C8H5F3O2 |
详情 | 详情
|
(II) |
17891 |
3-(trifluoromethyl)benzamide
|
1801-10-1 |
C8H6F3NO |
详情 | 详情
|
(III) |
17892 |
3-(trifluoromethyl)benzonitrile; alpha,alpha,alpha-Trifluoro-m-tolunitrile
|
368-77-4 |
C8H4F3N |
详情 | 详情
|
(IV) |
17893 |
3-(Trifluoromethyl)propiophenone; 1-[3-(trifluoromethyl)phenyl]-1-propanone
|
1533-03-5 |
C10H9F3O |
详情 | 详情
|
(V) |
17894 |
2-bromo-1-[3-(trifluoromethyl)phenyl]-1-propanone
|
|
C10H8BrF3O |
详情 |
详情
|
(VI) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(VII) |
17896 |
2-(tert-butylamino)-1-[3-(trifluoromethyl)phenyl]-1-propanone
|
|
C14H18F3NO |
详情 |
详情
|
合成路线29
该中间体在本合成路线中的序号:
(XIII) Reaction of 2,3,5,6-tetrafluoropyridine (I) with ammonia in formamide gives the 2-aminopyridine derivative (IV), which is condensed with tert-butylamine (XIII) in N-methylpyrrolidone to yield 6-(tert-butylamino)-3,5-di- fluoropyridine-2-amine (XIV). Condensation of amine (XIV) with 2-(3-chloro-2,4,5-trifluorobenzoyl)-3-ethoxyacrylic acid ethyl ester (VII) gives the adduct (XV), which is cyclized by means of K2CO3 in DMF to afford the quinolone derivative (XVI). Treatment of quinolone (XVI) with HCl in AcOH produces simultaneous ester hydrolysis and tert-butyl group removal, providing 4-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (XI). Finally, this compound is condensed with 3-hydroxyazetidine (XII) by means of N-methylpyrrolidine in DMF.
【2】
Ohshita, Y.; Kuramoto, Y.; Niino, Y.; Yazaki, A.; Structure-activity relationships of fluoroquinolones containing various heteroaromatics at N-1; WQ-3034/ABT-492 and its derivatives. 42nd Intersci Conf Antimicrob Agents Chemother (Sept 27 2002, San Diego) 2002, Abst F-544. |
【1】
Mealy, N.E.; Castaner, J.; ABT-492. Drugs Fut 2002, 27, 11, 1033.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
56640 |
2,3,5,6-Tetrafluoropyridine
|
2875-18-5 |
C5HF4N |
详情 | 详情
|
(IV) |
56642 |
3,5,6-trifluoro-2-pyridinamine; 3,5,6-trifluoro-2-pyridinylamine
|
|
C5H3F3N2 |
详情 |
详情
|
(VII) |
11682 |
ethyl (Z)-2-(3-chloro-2,4,5-trifluorobenzoyl)-3-ethoxy-2-propenoate
|
|
C14H12ClF3O4 |
详情 |
详情
|
(XI) |
56645 |
1-(6-amino-3,5-difluoro-2-pyridinyl)-8-chloro-6,7-difluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C15H6ClF4N3O3 |
详情 |
详情
|
(XII) |
31397 |
3-azetidinol
|
|
C3H7NO |
详情 |
详情
|
(XIII) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(XIV) |
56646 |
N~2~-(tert-butyl)-3,5-difluoro-2,6-pyridinediamine; N-(6-amino-3,5-difluoro-2-pyridinyl)-N-(tert-butyl)amine
|
|
C9H13F2N3 |
详情 |
详情
|
(XV) |
56647 |
ethyl (Z)-3-{[6-(tert-butylamino)-3,5-difluoro-2-pyridinyl]amino}-2-(3-chloro-2,4,5-trifluorobenzoyl)-2-propenoate
|
|
C21H19ClF5N3O3 |
详情 |
详情
|
(XVI) |
56648 |
ethyl 1-[6-(tert-butylamino)-3,5-difluoro-2-pyridinyl]-8-chloro-6,7-difluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C21H18ClF4N3O3 |
详情 |
详情
|
合成路线30
该中间体在本合成路线中的序号:
(V) NXY-059 is synthesized by condensation of N-tert-butylhydroxylamine (I) or its acetate or hydrochloride salts and disodium benzaldehyde-2,4-disulfonate (II) directly in refluxing MeOH or mixtures of MeOH/water or i-PrOH/MeOH/water or by means of MeONa in refluxing MeOH/water or i-PrOH/MeOH/water. N-tert-butylhydroxylamine (I) can be prepared as follows:
a) Reduction of 2-methyl-2-nitropropane (III) with either Zn in HOAc/EtOH or aluminum foil and HgCl2 in EtOH/ether/H2O.
b) Condensation of benzaldehyde (IV) with tert-butyl-amine (V) in refluxing toluene provides N-benzylidene-N-tert-butylamine (VI), which is oxidized with meta-chloroperbenzoic acid and Na2CO3 in water/toluene/ EtOH to furnish the phenyloxaziridine derivative (VII). Finally, the oxaziridine ring of (VII) is opened by treatment with H2SO4/HOAc in EtOH/H2O.
c) Heating of the phenyloxaziridine derivative (VII) at 130 C gives N-tert-butylphenylnitrone (VIII), which is finally treated with H2SO4/HOAc in toluene.
Disodium benzaldehyde-2,4-disulfonate (II) can be obtained as follows:
a) Heating of 2,4-dichlorobenzaldehyde (IX) with sodium sulfite at 170 °C in water in water, followed by oxidation with sodium hypochlorite.
b) Reaction of 2,4-dichlorobenzal chloride (X) with sodium sulfite and Na2CO3 or NaHCO3 at 170 C in water, followed by oxidation with sodium hypochlorite.
【1】
Leeson, P.A.; del Fresno, M.; Castañer, J.; Sorbera, L.A.; NXY-059. Drugs Fut 2002, 27, 3, 240.
|
【2】
Carney, J.M. (Oklahoma Medical Research Foundation; University of Kentucky); 2,4-Disulfo phenyl butyl nitrone, its salts and their use as pharmaceuticals. US 5780510 .
|
【3】
Carney, J.M. (Oklahoma Medical Research Foundation; University of Kentucky); 2,4-Disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals. WO 9517876 .
|
【4】
Metz, H.J. (Aventis Pharma AG); Process for the preparation of alkali metal and alkaline earth salts of benzaldehyde-2,4-disulfonic acid. DE 3434038; US 4715995 .
|
【5】
Metz, H.J. (Aventis Pharma AG); Process for the preparation of alkali metal and alkaline earth salts of benzaldehyde-2,4-di-sulfonic acid. DE 3434079; US 4710322 .
|
【6】
Blixt, J. (AstraZeneca AB); Novel salts of N-tert-butylhydroxylamine. WO 0002848 .
|
【7】
Kruk, H.; McGinley, J.; Pouhov, S.; Blixt, J.; Vajda, J. (AstraZeneca AB; Centaur Pharmaceuticals, Inc.); Novel process for the preparation of alpha-(2,4-disulfophenyl)-N-tert-butylnitrone and pharmaceutically acceptable salts thereof. WO 0151460 .
|
【8】
Wilcox, A.; Blixt, J.; Kruk, H.; Larsson, U.; McGinley, J.; Pouhov, S.; Vajda, J. (AstraZeneca AB; Centaur Pharmaceuticals, Inc.); Novel process for the preparation of alpha-(2,4-disulfophenyl)-N-tert-butylnitrone and pharmaceutically acceptable salts thereof. WO 0151461 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35455 |
N-(tert-butyl)hydroxylamine; 2-(hydroxyamino)-2-methylpropane
|
|
C4H11NO |
详情 |
详情
|
(II) |
37311 |
Benzaldehyde-2,4-disulfonic acid disodium; disodium 4-formyl-1,3-benzenedisulfonate
|
33513-44-9 |
C7H4Na2O7S2 |
详情 | 详情
|
(III) |
37310 |
2-methyl-2-nitropropane
|
594-70-7 |
C4H9NO2 |
详情 | 详情
|
(IV) |
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
(V) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(VI) |
52176 |
N-(tert-butyl)-N-[(Z)-benzylidene]amine; 2-methyl-N-[(Z)-benzylidene]-2-propanamine
|
|
C11H15N |
详情 |
详情
|
(VII) |
52177 |
2-(tert-butyl)-3-phenyl-1,2-oxaziridine
|
|
C11H15NO |
详情 |
详情
|
(VIII) |
52178 |
tert-butyl[(Z)-benzylidene]ammoniumolate
|
|
C11H15NO |
详情 |
详情
|
(IX) |
22196 |
2,4-dichlorobenzaldehyde
|
874-42-0 |
C7H4Cl2O |
详情 | 详情
|
(X) |
52179 |
2,4-dichloro-1-(dichloromethyl)benzene
|
|
C7H4Cl4 |
详情 |
详情
|
合成路线31
该中间体在本合成路线中的序号:
(VII) Treatment of 3,4-dibutoxy-3-cyclobutene-1,2-dione (VI) with tert-butylamine (VII) yielded the amino cyclobutenedione (VIII). Subsequent condensation of (VIII) with 3-chloro-4-(aminomethyl)benzonitrile (V) in THF provided the target diamino derivative.
【1】
Antane, M.M.; Herbst, D.R.; McFarlane, G.R.; Gundersen, E.G.; Hirth, B.H.; Quagliato, D.A.; Graceffa, R.F.; Butera, J.A.; Gilbert, A.M. (American Home Products Corp.); Substd. N-arylmethylamino derivs. of cyclobutene-3, 4-diones. US 5763474; US 5780505; WO 9802413 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
32962 |
4-(aminomethyl)-3-chlorobenzonitrile
|
|
C8H7ClN2 |
详情 |
详情
|
(VI) |
32963 |
3,4-dibutoxy-3-cyclobutene-1,2-dione
|
2892-62-8 |
C12H18O4 |
详情 | 详情
|
(VII) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(VIII) |
32964 |
3-butoxy-4-(tert-butylamino)-3-cyclobutene-1,2-dione
|
|
C12H19NO3 |
详情 |
详情
|
合成路线32
该中间体在本合成路线中的序号:
(II) Coupling of carboxylic acid (I) with tert-butylamine (II) by means of EDC-HOBt in CH2Cl2 affords carboxamide (III), whose Boc group is removed by treatment with HCl/dioxane to provide compound (IV). Coupling of thiazolidine (IV) to Boc-protected allophenylnorstatine (V) by means of DCC and HOBt in EtOAc provides derivative (VI), whose is deprotected by treatment with HCl/dioxane to yield (VII), which is then coupled to Boc-Val-OH (VIII) with EDC-HOBt in DMF to furnish compound (IX).
On the other hand, aminophenol derivative (XI) is condensed with benzyl chloroacetate (XII) in DMF in the presence of K2CO3 to furnish derivative (XIII), which is then debenzylated by hydrogenation over Pd/C in MeOH to yield acetic acid derivative (XIV).
Finally, the Boc group of (IX) is removed with HCl/dioxane and the resulting amine (X) is coupled to carboxylic acid (XIV) by first treatment with N-hydroxy-5-norbornene-2,3-dicarboximide (HONB) and DCC in CH2Cl2 followed by treatment with Et3N in DMF. Alternatively, the coupling can be performed by means of EDC and HOBt in DMF.
【1】
Takaku, H.; Hattori, N.; Mimoto, T.; et al.; Structure-activity relationship of orally potent tripeptide-based HIV protease inhibitors containing hydroxymethylcarbonyl isostere. Chem Pharm Bull 2000, 48, 9, 1310.
|
【2】
Terashima, K.; Mimoto, T.; Takaku, H.; Nojima, S.; Kiso, Y. (Japan Energy Corp.); Novel tripeptide cpds. and anti-AIDS drugs. EP 0900566; WO 9829118 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34777 |
(4R)-3-(tert-butoxycarbonyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
|
|
C11H19NO4S |
详情 |
详情
|
(II) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(III) |
45695 |
tert-butyl (4R)-4-[(tert-butylamino)carbonyl]-5,5-dimethyl-1,3-thiazolidine-3-carboxylate
|
|
C15H28N2O3S |
详情 |
详情
|
(IV) |
15836 |
N-t-BOC-(2R,3R)-3-Amino-2-hydroxy-4-phenylbutyric acid; (2S,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyric acid
|
116661-86-0 |
C15H21NO5 |
详情 | 详情
|
(V) |
45697 |
tert-butyl (1S,2S)-1-benzyl-3-[(4R)-4-[(tert-butylamino)carbonyl]-5,5-dimethyl-1,3-thiazolidin-3-yl]-2-hydroxy-3-oxopropylcarbamate
|
|
C25H39N3O5S |
详情 |
详情
|
(VI) |
45698 |
tert-butyl (1S)-1-[[((1S,2S)-1-benzyl-3-[(4R)-4-[(tert-butylamino)carbonyl]-5,5-dimethyl-1,3-thiazolidin-3-yl]-2-hydroxy-3-oxopropyl)amino]carbonyl]-2-methylpropylcarbamate
|
1638-63-7 |
C30H48N4O6S |
详情 | 详情
|
(VII) |
29294 |
(4R)-3-[(2S,3S)-3-amino-2-hydroxy-4-phenylbutanoyl]-N-(tert-butyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide
|
|
C20H31N3O3S |
详情 |
详情
|
(VIII) |
19733 |
(2S)-2-[(tert-butoxycarbonyl)amino]-3-methylbutyric acid
|
|
C10H19NO4 |
详情 |
详情
|
(IX) |
45698 |
tert-butyl (1S)-1-[[((1S,2S)-1-benzyl-3-[(4R)-4-[(tert-butylamino)carbonyl]-5,5-dimethyl-1,3-thiazolidin-3-yl]-2-hydroxy-3-oxopropyl)amino]carbonyl]-2-methylpropylcarbamate
|
1638-63-7 |
C30H48N4O6S |
详情 | 详情
|
(X) |
45699 |
(4R)-3-((2S,3S)-3-[[(2S)-2-amino-3-methylbutanoyl]amino]-2-hydroxy-4-phenylbutanoyl)-N-(tert-butyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide
|
|
C25H40N4O4S |
详情 |
详情
|
(XI) |
45700 |
N,N-Dimethyl-3-aminophenol; 3-Dimethylaminophenol; m-Dimethylaminophenol
|
99-07-0 |
C8H11NO |
详情 | 详情
|
(XII) |
45701 |
benzyl 2-chloroacetate
|
140-18-1 |
C9H9ClO2 |
详情 | 详情
|
(XIII) |
45702 |
benzyl 2-[3-(dimethylamino)phenoxy]acetate
|
|
C17H19NO3 |
详情 |
详情
|
(XIV) |
45703 |
2-[3-(dimethylamino)phenoxy]acetic acid
|
|
C10H13NO3 |
详情 |
详情
|
合成路线33
该中间体在本合成路线中的序号:
(IV) The condensation of vanillin (I) with epichlorohydrin (II) in ethanolic NaOH produced the glycidyl ether (III). Epoxide ring opening in (III) by means of tert-butylamine (IV) in EtOH furnished amino alcohol (V). The title dihydropyridine derivative was then obtained by reaction between aldehyde (V), methyl acetoacetate (VI), ammonia under Hantzsch condensation conditions, and was isolated after conversion to the hydrochloride salt.
【1】
Liang, J.-C.; Chen, I.-J.; Tsai, C.-H.; Liou, S.-F.; Wang, C.-S.; Yeh, J.-L.; The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities. Bioorg Med Chem 2002, 10, 3, 719. |
【2】
Donovan, S. (Allergan, Inc.); Method for treating a neoplasm. WO 0209743 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22701 |
4-hydroxy-3-methoxybenzaldehyde
|
121-33-5 |
C8H8O3 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
59599 |
3-methoxy-4-(2-oxiranylmethoxy)benzaldehyde
|
|
C11H12O4 |
详情 |
详情
|
(IV) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(V) |
59600 |
4-[3-(tert-butylamino)-2-hydroxypropoxy]-3-methoxybenzaldehyde
|
|
C15H23NO4 |
详情 |
详情
|
(VI) |
11791 |
methyl 3-oxobutanoate; Methyl acetoacetate
|
105-45-3 |
C5H8O3 |
详情 | 详情
|
合成路线34
该中间体在本合成路线中的序号:
(C) It can be prepared in several different ways:
1) By reaction of the 1-(2-cyanophenoxy)-2-hydroxy-3-bromopropane (I) with N,N'-di-tert-butylurea (A) in tetralin at 200 C.
2) By condensation of the 1-(2-cyanophenoxy)-2-hydroxy-3-bromopropane (I) with dihydropyrane (B) to the corresponding tetrahydropyranyl ether (III), which is condensed with tert-butylamine (C) in benzene to 1-(2-cyanophenoxy)-3-tert-butylaminopropanol-2-tetrahydropyranyl ether (IV) (oxalate, m.p. 102-5 C), which is finally hydrolyzed with diluted HCl at 100 C.
【1】
Koeppe, H.; et al. (Boehringer Ingelheim GmbH.); ZA 6803783 .
|
【2】
Castaner, J.; Chatterjee, S.S.; Bunitrolol. Drugs Fut 1976, 1, 5, 210.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
13684 |
3,4-Dihydro-2H-pyran;2,3-Dihydro-4H-pyran; 5,6-Dihydro-4H-pyran;Dihydropyran |
110-87-2 |
C5H8O |
详情 | 详情
|
(A) |
60731 |
N,N'-di(tert-butyl)urea
|
|
C9H20N2O |
详情 |
详情
|
(I) |
60728 |
2-(3-bromo-2-hydroxypropoxy)benzonitrile
|
|
C10H10BrNO2 |
详情 |
详情
|
(II) |
60729 |
2-[3-bromo-2-(tetrahydro-2H-pyran-2-yloxy)propoxy]benzonitrile
|
|
C15H18BrNO3 |
详情 |
详情
|
(IV) |
60730 |
2-[3-(tert-butylamino)-2-(tetrahydro-2H-pyran-2-yloxy)propoxy]benzonitrile
|
|
C19H28N2O3 |
详情 |
详情
|
(C) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线35
该中间体在本合成路线中的序号:
(C) It can be prepared in several different ways:
3) By hydrolysis of 1-(2-cyanophenoxy)-2-hydroxy-3-(N-acetyl-N-tert-butylamino)propane (V) with KOH in refluxing ethanol.
4) By heating N,N'-di-tert-butyl-N-[(2-hydroxy-3-O-cyanophenoxy)propyl]urea (VI) at 200 C in tetralin.
5) By condensation of the 1-(2-cyanophenoxy)-2,3-epoxypropane (II) with tert-butylamine (C) in ethanol.
【1】
Koeppe, H.; et al. (Boehringer Ingelheim GmbH.); ZA 6803783 .
|
【2】
Castaner, J.; Chatterjee, S.S.; Bunitrolol. Drugs Fut 1976, 1, 5, 210.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
37567 |
2-(2-oxiranylmethoxy)benzonitrile
|
|
C10H9NO2 |
详情 |
详情
|
(V) |
60732 |
N-(tert-butyl)-N-[3-(2-cyanophenoxy)-2-hydroxypropyl]acetamide
|
|
C16H22N2O3 |
详情 |
详情
|
(VI) |
60733 |
N,N'-di(tert-butyl)-N-[3-(2-cyanophenoxy)-2-hydroxypropyl]urea
|
|
C19H29N3O3 |
详情 |
详情
|
(C) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线36
该中间体在本合成路线中的序号:
(V) The selective methylation of 5,6,7,8-tetrahydro-5,8-ethanonaphthalene-1,4-diol (I) with dimethylsulfate in a two phase system gives 4-methoxy-5,6,7,8-tetrahydro-5,8-ethano-1-naphthol (II), which is condensed with epichlorohydrin (III) by means of piperidine at 100 C yielding 1-methoxy-4-(2,3-epoxypropoxy)-5,6,7,8-tetrahydro-5,8-ethanonaphthalene (IV). The reaction of (IV) with tert-butylamine (V) at 100 C affords 1-methoxy-4-[3-(tert-butylamino)-2-hydroxypropoxy]-5,6,7,8-tetrahydro-5,8-ethanonaphthalene (VI), which is finally demethylated by treatment with pyridine hydrochloride at 160 C
【1】
Blancafort, P.; Serradell, M.N.; Castaner, J.; McGillion, F.B.; Nafetolol. Drugs Fut 1981, 6, 2, 92.
|
【2】
Momiyama, N.; Ichikawa, Y.; Hasegawa, S.; Ishikawa, T.; Matsuyama, R.; Miazaki, K.; Shimada, H.; Targeting MMP-7 via antisense oligonucleotide shows anti-metastatic effects in a colon cancer murine model. Eur J Med Chem 1974, 9, 5, 501.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
61070 |
tricyclo[6.2.2.0~2,7~]dodeca-2,4,6-triene-3,6-diol
|
|
C12H14O2 |
详情 |
详情
|
(II) |
61071 |
6-methoxytricyclo[6.2.2.0~2,7~]dodeca-2,4,6-trien-3-ol
|
|
C13H16O2 |
详情 |
详情
|
(III) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
60172 |
4,5,6,7-tetrahydro-1H-cyclopenta[a]pyrrolo[3,4-c]carbazole-1,3(2H)-dione
|
|
C17H12N2O2 |
详情 |
详情
|
(V) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(VI) |
60173 |
10-bromo-4,5,6,7-tetrahydro-1H-cyclopenta[a]pyrrolo[3,4-c]carbazole-1,3(2H)-dione
|
|
C17H11BrN2O2 |
详情 |
详情
|
合成路线37
该中间体在本合成路线中的序号:
(V) The selective hydrolysis of 1,4-diacetoxy-5,6,7,8-tetrahydro-5,8-ethanonaphthalene (VII) with diethylamine in methanol gives 4-acetoxy-5,6,7,8-tetrahydro-5,8-ethano-1-naphthol (VIII), which is condensed with epichlorohydrin (III) by means of piperidine at 90 C to afford 1-acetoxy-4-(2,3-epoxypropoxy)-5,6,7,8-tetrahydro-5,8-ethanonaphthalene (VII). The reaction of (IX) with tert-butylamine (V) in refluxing toluene gives 1-acetoxy-4-[3-(tert-butylamino)-2-hydroxypropoxy]-5,6,7,8-tetrahydro-5,8-ethanonaphthalene (X), which is finally hydrolyzed with dry HCl in refluxing methanol
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(VII) |
61074 |
6-(acetyloxy)tricyclo[6.2.2.0~2,7~]dodeca-2,4,6-trien-3-yl acetate
|
|
C16H18O4 |
详情 |
详情
|
(VIII) |
61075 |
6-hydroxytricyclo[6.2.2.0~2,7~]dodeca-2,4,6-trien-3-yl acetate
|
|
C14H16O3 |
详情 |
详情
|
(IX) |
61076 |
6-(2-oxiranylmethoxy)tricyclo[6.2.2.0~2,7~]dodeca-2,4,6-trien-3-yl acetate
|
|
C17H20O4 |
详情 |
详情
|
(X) |
61077 |
6-[3-(tert-butylamino)-2-hydroxypropoxy]tricyclo[6.2.2.0~2,7~]dodeca-2,4,6-trien-3-yl acetate
|
|
C21H31NO4 |
详情 |
详情
|
合成路线38
该中间体在本合成路线中的序号:
(I)
【1】
Krishnan L, Sum PE, Daigneault S, et aL. 2006. Process for the prepantion of tigecycline and methods of preparing 9-aminominocycline. W0 2006130500 |
【2】
Krishnan L, Sum PE, Daigneault S, et al. 2006. Preparation of tigecycline and 9-nitrominocycline. W0 2006130501 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
66846 |
(4S,4aS,5aR,12aS)-9-amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide hydrochloride |
|
C23H28N4O7.HCl |
详情 | 详情
|
(I) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(II) |
17430 |
2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate
|
5292-43-3 |
C6H11BrO2 |
详情 | 详情
|
(III) |
66841 |
tert-butyl 2-(tert-butylamino)acetate |
|
C10H21NO2 |
详情 | 详情
|
(IV) |
66842 |
2-(tert-butylamino)acetic acid hydrochloride |
|
C6H13NO2.HCl |
详情 | 详情
|
(V) |
66843 |
2-(tert-butylamino)acetyl chloride hydrochloride |
|
C6H12ClNO.HCl |
详情 | 详情
|
(VI) |
65813 |
Minocycline hydrochloride; [4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride |
13614-98-7 |
C23H27N3O7.HCl |
详情 | 详情
|
(VII) |
66844 |
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide monosulfate |
|
C23H26N4O9.2H2SO4 |
详情 | 详情
|
(VIII) |
66845 |
(4S,4aS,5aR,12aS)-9-amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide monosulfate |
|
C23H28N4O7.2H2SO4 |
详情 | 详情
|
合成路线39
该中间体在本合成路线中的序号:
(VI)
【1】
Venkataraman S, RAO UVB, Muwa V, et al. 2006. Process for the preparation of highly pure zipnsidone hydrochloride. US 2006089502 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(I) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(II) |
16275 |
6-chloro-1,3-dihydro-2H-indol-2-one
|
56341-37-8 |
C8H6ClNO |
详情 | 详情
|
(III) |
16276 |
6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one
|
|
C10H7Cl2NO2 |
详情 |
详情
|
(IV) |
16277 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one-
|
|
C10H9Cl2NO |
详情 |
详情
|
(V) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|